JP2019529571A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2019529571A5 JP2019529571A5 JP2019538580A JP2019538580A JP2019529571A5 JP 2019529571 A5 JP2019529571 A5 JP 2019529571A5 JP 2019538580 A JP2019538580 A JP 2019538580A JP 2019538580 A JP2019538580 A JP 2019538580A JP 2019529571 A5 JP2019529571 A5 JP 2019529571A5
- Authority
- JP
- Japan
- Prior art keywords
- composition according
- functional rna
- rna molecule
- composition
- small molecule
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201662403595P | 2016-10-03 | 2016-10-03 | |
| US62/403,595 | 2016-10-03 | ||
| PCT/US2017/054884 WO2018067526A1 (en) | 2016-10-03 | 2017-10-03 | Functional rna and small-molecule drug therapeutic complexes and nanoparticle delivery vehicles |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2019529571A JP2019529571A (ja) | 2019-10-17 |
| JP2019529571A5 true JP2019529571A5 (enExample) | 2020-11-12 |
Family
ID=61831202
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2019538580A Pending JP2019529571A (ja) | 2016-10-03 | 2017-10-03 | 機能性ｒｎａと小分子薬の治療用複合体、およびナノ粒子送達ビヒクル |
Country Status (7)
| Country | Link |
|---|---|
| US (1) | US20190240344A1 (enExample) |
| EP (1) | EP3518939A4 (enExample) |
| JP (1) | JP2019529571A (enExample) |
| CN (1) | CN109890393A (enExample) |
| AU (1) | AU2017339456A1 (enExample) |
| CA (1) | CA3039040A1 (enExample) |
| WO (1) | WO2018067526A1 (enExample) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2010085665A2 (en) | 2009-01-23 | 2010-07-29 | Cedars-Sinai Medical Center | Targeted delivery system |
| EP3791889B1 (en) | 2014-01-17 | 2024-02-21 | Cedars-Sinai Medical Center | C-met receptor targeting constructs and uses thereof |
| MX2020006890A (es) * | 2018-01-02 | 2020-09-07 | Cedars Sinai Medical Center | Nanoparticulas para la administracion dirigida de polipeptidos terapeuticos. |
| CN109432430B (zh) * | 2018-11-22 | 2021-12-17 | 华南理工大学 | 一种siRNA和抗癌药物疏水性复合物及其制备方法与应用 |
| CN119015258A (zh) * | 2019-09-06 | 2024-11-26 | 加利福尼亚大学董事会 | 核酸介导的治疗剂的递送 |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU6762600A (en) * | 1999-08-09 | 2001-03-05 | General Hospital Corporation, The | Drug-carrier complexes and methods of use thereof |
| AU2003282877B9 (en) * | 2002-09-25 | 2011-05-12 | University Of Massachusetts | In Vivo gene silencing by chemically modified and stable siRNA |
| US9078927B2 (en) * | 2007-07-06 | 2015-07-14 | Cedars-Sinai Medical Center | Self-assembling complex for targeting chemical agents to cells |
| JP5252618B2 (ja) * | 2007-10-26 | 2013-07-31 | 独立行政法人産業技術総合研究所 | ＲＮＡ干渉効果が高い芳香環修飾ｓｉＲＮＡ |
| WO2010085665A2 (en) * | 2009-01-23 | 2010-07-29 | Cedars-Sinai Medical Center | Targeted delivery system |
| EP3791889B1 (en) * | 2014-01-17 | 2024-02-21 | Cedars-Sinai Medical Center | C-met receptor targeting constructs and uses thereof |
| CA3025348A1 (en) * | 2016-05-27 | 2017-11-30 | Cedars-Sinai Medical Center | Drug-delivery nanoparticles and treatments for drug-resistant cancer |
-
2017
- 2017-10-03 US US16/338,909 patent/US20190240344A1/en not_active Abandoned
- 2017-10-03 WO PCT/US2017/054884 patent/WO2018067526A1/en not_active Ceased
- 2017-10-03 AU AU2017339456A patent/AU2017339456A1/en not_active Abandoned
- 2017-10-03 CA CA3039040A patent/CA3039040A1/en not_active Abandoned
- 2017-10-03 EP EP17858997.4A patent/EP3518939A4/en not_active Withdrawn
- 2017-10-03 JP JP2019538580A patent/JP2019529571A/ja active Pending
- 2017-10-03 CN CN201780061209.0A patent/CN109890393A/zh active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2019529571A5 (enExample) | ||
| US11242532B2 (en) | Self-assembled 3D RNA cage nanoparticles | |
| Taghdisi et al. | Reversible targeting and controlled release delivery of daunorubicin to cancer cells by aptamer-wrapped carbon nanotubes | |
| Zhao et al. | Magnesium-stabilized multifunctional DNA nanoparticles for tumor-targeted and pH-responsive drug delivery | |
| Tyagi et al. | Exploiting nanotechnology for the development of microRNA-based cancer therapeutics | |
| CN110573184B (zh) | Rna纳米结构，其制备方法和用途 | |
| Yao et al. | Targeted therapy of colon cancer by aptamer-guided holliday junctions loaded with doxorubicin | |
| JP2019506862A5 (enExample) | ||
| JP2015516989A5 (enExample) | ||
| EP2700414B1 (en) | Self-gelatinizable nucleic acid | |
| Luo et al. | Framework nucleic acid-based multifunctional tumor theranostic nanosystem for miRNA fluorescence imaging and chemo/gene therapy | |
| JP2017514800A5 (enExample) | ||
| Manikkath et al. | Nanoparticulate strategies for the delivery of miRNA mimics and inhibitors in anticancer therapy and its potential utility in oral submucous fibrosis | |
| Ngamcherdtrakul et al. | Current development of targeted oligonucleotide-based cancer therapies: Perspective on HER2-positive breast cancer treatment | |
| EP3600341A1 (en) | Gemcitabine derivatives for cancer therapy | |
| JP2019517477A5 (enExample) | ||
| Song et al. | Self‐Assembled DNA Nanostructures for Biomedical Applications | |
| Almalki et al. | Advances in the polymeric nanoparticulate delivery systems for RNA therapeutics | |
| CN109890393A (zh) | 功能rna和小分子药物治疗性复合物和纳米颗粒递送媒介 | |
| JP2013530685A5 (enExample) | ||
| US20170014521A1 (en) | Pharmaceutical compositions for high-capacity targeted delivery | |
| WO2014194250A3 (en) | Novel nanocarrier delivered cancer chemotherapeutic agents | |
| WO2017162185A1 (zh) | 对非小细胞肺癌具有抑制作用的核糖核酸适配体及包含其的药物组合物 | |
| CN105814202B (zh) | Notch1特异性sirna分子 | |
| JP2016533190A5 (enExample) |